SEARCH
7% increase in international HCP visits across 13 brand sites in five countries, languages and cultures despite Google Ad Words ban for a major pharma multinational.
Problem
Drive HCP traffic in the face of regulatory uncertainties as Google suddenly disallows drug claim/brand association, threatening to collapse international paid search traffic to 13 branded sites in five countries.
Solution
A proprietary portfolio of global tactics to replace Google Ad Words that includes:
- Worldwide Yahoo! and Bing search
- International opt-in HCP email campaigns
- Targeted global banner ad campaigns
© Boomerang Pharmaceutical Communications